Anthropic's Claude just hit a 93% success rate designing protein binders from scratch—14 out of 15 targets nailed. Adaptyv Bio and Twist Bioscience both validated independently.
This isn't hype. AI designing proteins at this accuracy means we're watching biotech get compressed into cycles that used to take years.
If AI can do this for proteins, imagine what happens when it starts optimizing DeSci protocols, tokenomics, or cross-chain infrastructure at scale.
The convergence is coming faster than most realize.
This isn't hype. AI designing proteins at this accuracy means we're watching biotech get compressed into cycles that used to take years.
If AI can do this for proteins, imagine what happens when it starts optimizing DeSci protocols, tokenomics, or cross-chain infrastructure at scale.
The convergence is coming faster than most realize.
